These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28216253)

  • 1. [Atrial fibrillation and anticoagulation in hemodialysis patients: A complex decision].
    Delanaye P; Bouquegneau A; Dubois BE; Sprynger M; Mariat C; Krzesinski JM; Lancellotti P
    Nephrol Ther; 2017 Apr; 13(2):59-66. PubMed ID: 28216253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
    Van Der Meersch H; De Bacquer D; De Vriese AS
    Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?
    Sood MM; Komenda P; Sood AR; Rigatto C; Bueti J
    Chest; 2009 Oct; 136(4):1128-1133. PubMed ID: 19809054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
    Yoon CY; Noh J; Jhee JH; Chang TI; Kang EW; Kee YK; Kim H; Park S; Yun HR; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Kim C; Yoo TH
    Stroke; 2017 Sep; 48(9):2472-2479. PubMed ID: 28801476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilemmas in the management of atrial fibrillation in chronic kidney disease.
    Reinecke H; Brand E; Mesters R; Schäbitz WR; Fisher M; Pavenstädt H; Breithardt G
    J Am Soc Nephrol; 2009 Apr; 20(4):705-11. PubMed ID: 19092127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulants, renal failure and atrial fibrillation.
    Genovesi S; Santoro A
    Expert Opin Drug Saf; 2013 Jan; 12(1):1-3. PubMed ID: 23163428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Vitamins K antagonists in non-valvular atrial fibrillation thromboembolic risk prevention in Burkina Faso.
    Yameogo AR; Kologo JK; Mandi G; Kabore HP; Millogo GR; Seghda AA; Samadoulougou AK; Zabsonre P
    Pan Afr Med J; 2016; 24():108. PubMed ID: 27642447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' Characteristics Affect the Survival Benefit of Warfarin Treatment for Hemodialysis Patients with Atrial Fibrillation. A Historical Cohort Study.
    Brancaccio D; Neri L; Bellocchio F; Barbieri C; Amato C; Mari F; Canaud B; Stuard S
    Am J Nephrol; 2016; 44(4):258-267. PubMed ID: 27598317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of stroke in patients with atrial fibrillation.
    Olsson SB; Halperin JL
    Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
    Garwood CL; Hwang JM; Moser LR
    Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and warfarin use in haemodialysis patients: an individualized holistic approach is important in stroke prevention.
    Thet Z; Vilayur E
    Nephrology (Carlton); 2013 May; 18(5):331-9. PubMed ID: 23521615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentre F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Cerebrovasc Dis; 2001; 12(3):245-52. PubMed ID: 11641591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?
    Vázquez E; Sánchez-Perales C; García-Cortes MJ; Borrego F; Lozano C; Guzmán M; Gil JM; Liébana A; Pérez P; Borrego MJ; Pérez V
    Int J Cardiol; 2003 Feb; 87(2-3):135-9; discussion 139-41. PubMed ID: 12559531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation?
    Fiaccadori E; Maggiore U; Regolisti G
    Nephrol Dial Transplant; 2013 Dec; 28(12):2923-8. PubMed ID: 24026242
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?
    Sánchez-González C; Herrero Calvo JA
    Nefrologia (Engl Ed); 2022; 42(6):633-644. PubMed ID: 36907719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
    Chan KE; Edelman ER; Wenger JB; Thadhani RI; Maddux FW
    Circulation; 2015 Mar; 131(11):972-9. PubMed ID: 25595139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
    Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Senoo K; Lip GY
    Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?
    Shen JI; Turakhia MP; Winkelmayer WC
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):600-6. PubMed ID: 23079746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.